Literature DB >> 7836091

Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula.

M Barton1.   

Abstract

PURPOSE: To provide a simple method of showing the equivalent dose in 2 Gy fractions for various treatment regimens using the linear quadratic (LQ) formula. METHODS AND MATERIALS: Tables of equivalent dose for common total doses and fraction sizes have been calculated using the LQ formula for representative alpha:beta ratios (1, 3, 10). Corrections have not been made for repopulation. Examples are given.
CONCLUSION: The tables offer a simple method of equating one fractionation regimen with another, recognizing the limitation of this method.

Mesh：

Year:  1995        PMID： 7836091     DOI： 10.1016/0360-3016(94)E0126-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  13 in total

1.  Improved outcome following preoperative radiochemotherapy: 40.5 Gy accelerated hyperfractionation and 5-fluorouracil suppositories for patients with carcinoma of the lower rectum.

Authors:  H Horie; H Kashiwagi; F Konishi; K Furuta; A Ozawa; K Kanazawa
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neck.

Authors:  Sewit Teckie; Benjamin H Lok; Shyam Rao; Stanley I Gutiontov; Yoshiya Yamada; Sean L Berry; Michael J Zelefsky; Nancy Y Lee
Journal:  Oral Oncol       Date:  2016-07-12       Impact factor: 5.337

3.  Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting.

Authors:  Natsuko Imaizumi; Yan Monnier; Monika Hegi; René-Olivier Mirimanoff; Curzio Rüegg
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

4.  A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).

Authors:  Jeffrey Allen; Bernadine Donahue; Minesh Mehta; Douglas C Miller; Lucy B Rorke; Regina Jakacki; Patricia Robertson; Richard Sposto; Emi Holmes; Gilbert Vezina; Karin Muraszko; Diane Puccetti; Michael Prados; Ka-Wah Chan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-07       Impact factor: 7.038

5.  A Radiation-Induced Hippocampal Vascular Injury Surrogate Marker Predicts Late Neurocognitive Dysfunction.

Authors:  Reza Farjam; Priyanka Pramanik; Madhava P Aryal; Ashok Srinivasan; Christopher H Chapman; Christina I Tsien; Theodore S Lawrence; Yue Cao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-08-08       Impact factor: 7.038

6.  Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults.

Authors:  Christopher L Tinkle; Charu Singh; Shane Lloyd; Yian Guo; Yimei Li; Alberto S Pappo; Steven G DuBois; John T Lucas; Daphne A Haas-Kogan; Stephanie A Terezakis; Steve E Braunstein; Matthew J Krasin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-11-28       Impact factor: 7.038

7.  CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung Cancer.

Authors:  Viola J Chen; Eric Oermann; Saloomeh Vahdat; Jennifer Rabin; Simeng Suy; Xia Yu; Sean P Collins; Deepa Subramaniam; Filip Banovac; Eric Anderson; Brian T Collins
Journal:  Front Oncol       Date:  2012-02-01       Impact factor: 6.244

8.  Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy.

Authors:  Cheng-Hsiang Lo; Jen-Fu Yang; Ming-Yueh Liu; Yee-Min Jen; Chun-Shu Lin; Hsing-Lung Chao; Wen-Yen Huang
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

9.  Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer.

Authors:  Brian T Collins; Saloomeh Vahdat; Kelly Erickson; Sean P Collins; Simeng Suy; Xia Yu; Ying Zhang; Deepa Subramaniam; Cristina A Reichner; Ismet Sarikaya; Giuseppe Esposito; Shadi Yousefi; Carlos Jamis-Dow; Filip Banovac; Eric D Anderson
Journal:  J Hematol Oncol       Date:  2009-01-17       Impact factor: 17.388

Review 10.  Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits.

Authors:  K J Ray; N R Sibson; A E Kiltie
Journal:  Clin Oncol (R Coll Radiol)       Date:  2015-03-07       Impact factor: 4.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.